A Generic Platform for Cellular Screening Against Ubiquitin Ligases

Timurs Maculins, Nikki Carter, Thierry Dorval, Kevin Hudson, J. Willem M Nissink, Ronald T. Hay, Husam Alwan (Lead / Corresponding author)

    Research output: Contribution to journalArticlepeer-review

    18 Citations (Scopus)
    177 Downloads (Pure)


    Ubiquitin signalling regulates most aspects of cellular life, thus deregulation of ubiquitylation has been linked with a number of diseases. E3 ubiquitin ligases provide substrate selectivity in ubiquitylation cascades and are therefore considered to be attractive targets for developing therapeutic molecules. In contrast to established drug target classes, such as protein kinases, GPCRs, hormone receptors and ion channels, ubiquitin drug discovery is in its early stages. This is, in part, due to the complexity of the ubiquitylation pathways and the lack of robust quantitative technologies that allow high-throughput screening of inhibitors. Here we report the development of a Ubiquitin Ligase Profiling system, which is a novel and generic cellular technology designed to facilitate identification of selective inhibitors against RING type E3 ubiquitin ligases. Utilization of this system requires a single co-transfection of cells with assay vectors, thereby enabling readout of E3 ubiquitin ligase catalytic activity within the cellular environment. Therefore, our robust high-throughput screening platform offers novel opportunities for the development of inhibitors against this difficult-to-target E3 ligase enzyme class.

    Original languageEnglish
    Article number18940
    JournalScientific Reports
    Early online date8 Jan 2016
    Publication statusPublished - 8 Jan 2016

    ASJC Scopus subject areas

    • General


    Dive into the research topics of 'A Generic Platform for Cellular Screening Against Ubiquitin Ligases'. Together they form a unique fingerprint.

    Cite this